HUL Q4 2025 Earnings Call Transcript Released; FY27 Growth Expected to Exceed FY26
HUL's Q4 2025 earnings call transcript reveals 5% USG and 4% UVG. EBITDA grew 3% to ₹3,788 crore. Reported PAT surged 121% to ₹6,603 crore due to demerger impacts. The company is investing in quick commerce and D2C brands like OZiva and Minimalist. FY27 growth is projected to exceed FY26.
The announcement includes key financial performance indicators, strategic initiatives like investment in new channels and acquisitions, organizational changes aimed at agility, and a positive future outlook. These factors are material to investors and stakeholders, indicating significant company direction and performance.
The company reported positive sales and volume growth, with improved EBITDA and a significant jump in reported PAT. The outlook for FY27 is optimistic, anticipating better growth than FY26, driven by strategic initiatives and a conducive operating environment. The acquisition of OZiva further signals a positive growth trajectory.
Hindustan Unilever Limited (HUL) has released the transcript of its earnings call for the quarter and nine months ended December 31, 2025. The call, which took place on February 12th, 2026, featured insights from CEO & Managing Director Priya Nair and CFO Niranjan Gupta.
The company reported an Underlying Sales Growth (USG) of 5% for the quarter, driven by an Underlying Volume Growth (UVG) of 4%. This growth was broad-based across categories. EBITDA stood at ₹3,788 crore, up 3% year-on-year, with an EBITDA margin of 23.3%. Profit After Tax (PAT) before exceptional items was ₹2,562 crore, a 1% increase year-on-year. Reported PAT grew significantly by 121% to ₹6,603 crore, attributed to one-off impacts from the demerger of the Ice Cream business and fair valuation of OZiva, as well as the income from the sale of the water business in December 2024.
Key strategic priorities discussed include consumer segmentation, crafting relevant brands, future-proofing the sales and marketing engine, and focusing on fewer, bigger bets. The company highlighted progress in building "SASSY" brands, investing in channels of the future like quick commerce (now 3% of business, growing 100% quarter-on-quarter), and scaling its D2C presence with brands like Minimalist and OZiva, which together have an Annual Recurring Revenue (ARR) of ₹1,100 crore.
Organizational changes were implemented in January 2026 to create a simpler, more agile structure, with Business Unit Heads now reporting directly to the CEO to accelerate decision-making. Unilever R&D has also established an India-focused organization to enhance science-led innovation.
Looking ahead, HUL expects the operating environment to remain conducive for consumption recovery. The company anticipates that financial year 2027 will show better growth than financial year 2026. Consolidated EBITDA margins are expected to remain within the guided range. The company also announced the acquisition of the remaining 49% stake in OZiva for ₹824 crore and the divestment of its minority stake in Nutrition Lab Private Limited to USV Private Limited for ₹307 crore.
What to do with a filing like this
Hindustan Unilever Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Hindustan Unilever Limited. Read the original for the full detail.